1. Home
  2. SYBX vs LEDS Comparison

SYBX vs LEDS Comparison

Compare SYBX & LEDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SYBX
  • LEDS
  • Stock Information
  • Founded
  • SYBX N/A
  • LEDS 2005
  • Country
  • SYBX United States
  • LEDS Taiwan
  • Employees
  • SYBX N/A
  • LEDS N/A
  • Industry
  • SYBX Biotechnology: Pharmaceutical Preparations
  • LEDS Semiconductors
  • Sector
  • SYBX Health Care
  • LEDS Technology
  • Exchange
  • SYBX Nasdaq
  • LEDS Nasdaq
  • Market Cap
  • SYBX 20.0M
  • LEDS 21.8M
  • IPO Year
  • SYBX N/A
  • LEDS 2010
  • Fundamental
  • Price
  • SYBX $1.75
  • LEDS $2.45
  • Analyst Decision
  • SYBX
  • LEDS
  • Analyst Count
  • SYBX 0
  • LEDS 0
  • Target Price
  • SYBX N/A
  • LEDS N/A
  • AVG Volume (30 Days)
  • SYBX 50.2K
  • LEDS 54.5K
  • Earning Date
  • SYBX 11-11-2025
  • LEDS 11-07-2025
  • Dividend Yield
  • SYBX N/A
  • LEDS N/A
  • EPS Growth
  • SYBX N/A
  • LEDS N/A
  • EPS
  • SYBX N/A
  • LEDS N/A
  • Revenue
  • SYBX N/A
  • LEDS $31,108,000.00
  • Revenue This Year
  • SYBX N/A
  • LEDS N/A
  • Revenue Next Year
  • SYBX N/A
  • LEDS N/A
  • P/E Ratio
  • SYBX N/A
  • LEDS N/A
  • Revenue Growth
  • SYBX N/A
  • LEDS 485.62
  • 52 Week Low
  • SYBX $0.90
  • LEDS $1.20
  • 52 Week High
  • SYBX $1.96
  • LEDS $3.37
  • Technical
  • Relative Strength Index (RSI)
  • SYBX 49.98
  • LEDS 45.77
  • Support Level
  • SYBX $1.52
  • LEDS $2.36
  • Resistance Level
  • SYBX $1.86
  • LEDS $3.32
  • Average True Range (ATR)
  • SYBX 0.12
  • LEDS 0.28
  • MACD
  • SYBX -0.01
  • LEDS -0.07
  • Stochastic Oscillator
  • SYBX 42.86
  • LEDS 9.91

About SYBX Synlogic Inc.

Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.

About LEDS SemiLEDS Corporation

SemiLEDs Corp develops, manufactures, and sells light-emitting diode chips and LED components. The company's products include LED Chips, LED Components, and Lighting Products. Its products are used for general lighting applications, including street lights and commercial, industrial, system, and residential lighting; specialty industrial applications, such as ultraviolet, or Ultraviolet, curing of polymers, LED light therapy in medical/cosmetic applications, counterfeit detection, LED lighting for horticulture applications, architectural lighting and entertainment lighting. Substantial revenue is generated from the sale of LED components products. Geographically, it derives a majority of its revenue from Japan.

Share on Social Networks: